ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstracts tagged "treatment and treatment"

  • Abstract Number: 978 • ACR/ARP Annual Meeting 2019

    Light Mediated Therapeutics in Arthritis

    Victoria Wickenheisser1, Emily Rabjohns 2, Emilia Zywot 3, Natalia Orlova 3, Christina Marvin 3, Song Ding 4, David Lawrence 4 and Teresa Tarrant 5, 1Duke University School of Medicine, Durham, 2Department of Rheumatology, Duke University Hospital, Durham, NC, 3UNC Department of Chemistry, Chapel Hill, NC, 4Division of Medicinal Chemistry and Chemical Biology The UNC Eshelman School of Pharmacy at UNC, Chapel Hill, NC, 5Department of Medicine Division of Rheumatology and Immunology, Duke University Hospital, Durham, NC

    Background/Purpose: Rheumatoid arthritis (RA) therapies are constrained by the failure to deliver sufficient quantities of drug to the inflamed site, systemic side effects, and the…
  • Abstract Number: 603 • ACR/ARHP Annual Meeting 2018

    Rheumatologists Beliefs in the Effectiveness of Other Methotrexate-Based Treatment Approaches May Explain the Low Use of Triple Therapy: A Bayesian Belief Elicitation

    Gyanendra Pokharel1, Rob Deardon1, Sindhu Johnson2, George A. Tomlinson3 and Glen Hazlewood4, 1Department of Mathematics and Statistics, University of Calgary, Calgary, AB, Canada, 2Rheumatology, Mount Sinai Hospital and University Health Network, Toronto, ON, Canada, 3Medicine, Mount Sinai Hospital, Toronto, ON, Canada, 4Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Triple therapy (MTX, sulphasalazine (SSZ), hydroxychloroquine (HCQ)) has evidence to support its use from randomized trials (RCTs) but is not commonly used. The objective…
  • Abstract Number: 2353 • ACR/ARHP Annual Meeting 2018

    Attitudes and Beliefs Regarding Methotrexate in Patients with Rheumatoid Arthritis: Results from Australian Rheumatology Association Database

    Nieves Leonardo1,2, Susan Lester3,4, Michelle Graham5, Samuel Whittle1,6, Debra Rowett7,8, Rachelle Buchbinder9,10 and Catherine Hill6,11,12, 1Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia, 2Rheumatology, The Queen Elizabeth Hospital, Adelaide, Australia, 3Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, 4Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia, 5Arthritis Queensland, Queensland, Australia, 6The Queen Elizabeth Hospital, Adelaide, Australia, 7School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia, 8Drug and Therapeutics Information Service, Southern Adelaide Local Health Network, Adelaide, Australia, 9Cabrini Institute, Victoria, Australia, 10Monash University, Melbourne, Australia, 11Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, 12Medicine, The University of Adelaide, Adelaide, Australia

    Background/Purpose: To determine beliefs about methotrexate (MTX) in patients with Rheumatoid Arthritis (RA) in relation to views obtained from a range of information sources.Methods: RA…
  • Abstract Number: 497 • ACR/ARHP Annual Meeting 2016

    The Identification of an ACR Score with the Optimal Discriminatory Ability Between Treatments in Patients with Early and Established Rheumatoid Arthritis

    Josef Smolen1, Roy Fleischmann2, Daniel Aletaha3, Yihan Li4, Stefan Florentinus4 and Ivan Lagunes Galindo4, 1Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 2Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 3Medical University Vienna and Hietzing Hospital, Vienna, Austria, 4AbbVie Inc., North Chicago, IL

                                                                                                                           Background/Purpose: In patients (pts) with rheumatoid arthritis (RA), the American College of Rheumatology (ACR)20 score was developed to best discriminate effective from placebo…
  • Abstract Number: 1586 • ACR/ARHP Annual Meeting 2015

    Weight Loss in Obese Rheumatoid Arthritis (RA) Patients Improves Disease Activity without Modifying RA Treatment

    Elisa Gremese1, Maria Rita Gigante1, Barbara Tolusso1, Anna Laura Fedele1, Silvia Canestri1, Barbara Aquilanti2, Clara Di Mario1, Luca Petricca1, Stefano Alivernini1 and Gianfranco Ferraccioli1, 1Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 2Dietology Service, Association Columbus, Catholic University of the Sacred Heart, Rome, Italy

    Background/Purpose: Obesity is recognized as a systemic, low-grade inflammatory state and the adipose tissue as an endocrine organ releasing pro-inflammatory cytokines. On the other hand,…
Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology